CD44 and ovarian cancer: In vitro assessment of cellular uptake in CR SKOV-3 cells revealed a preferential uptake of HA@MOF@Cy 5.5 into CR SKOV-3 ovarian cancer cells overexpressing CD44 (a cell surface glycoprotein).